LACTOBACILLUS PARACASEI STRAIN AND ITS APPLICATIONS

Claims

1. Lactobacillus paracasei strain KBL385 with identification number KCTC13511 BP.

2. The strain according to claim 1, characterized in that said strain contains the 16s rDNA sequence SEQ ID NO:

3.

3. A food composition containing an effective amount of at least one component selected from the group consisting of a strain according to claim 1 or 2, a culture of said strain, a lysate of said strain, and an extract of said strain.

4. A food additive composition comprising an effective amount of at least one component selected from the group consisting of a strain according to claim 1 or 2, a culture of said strain, a lysate of said strain, and an extract of said strain.

5. The food composition according to claim 3, characterized in that said composition is a functional health food composition for improving intestinal health.

6. A pharmaceutical composition for the treatment or prevention of intestinal diseases, containing an effective amount of at least one component selected from the group consisting of a strain according to claim 1 or 2, a culture of said strain, a lysate of said strain, and an extract of said strain.

7. The pharmaceutical composition according to claim 6, characterized in that said intestinal diseases are selected from the group consisting of flatulence, abdominal discomfort, infectious diarrhea caused by pathogenic microorganisms, gastroenteritis, inflammatory bowel disease, neurogenic intestinal syndrome, irritable bowel syndrome, small intestinal microbial overgrowth, and intestinal food diarrhea.

8. The food composition according to claim 3, characterized in that said composition is a functional health food composition for improving allergy symptoms.

9. A pharmaceutical composition for the treatment or prevention of allergic diseases, containing an effective amount of at least one component selected from the group consisting of a strain according to claim 1 or 2, a culture of said strain, a lysate of said strain, and an extract of said strain.

10. The pharmaceutical composition according to claim 9, characterized in that said allergic disease is atopic dermatitis, urticaria, allergic rhinitis, allergic conjunctivitis, asthma, food allergy or anaphylactic shock.

11. A food composition according to claim 3, characterized in that said composition is a functional health food composition for the relief of autoimmune diseases or inflammatory diseases.

12. A pharmaceutical composition for the treatment or prevention of autoimmune diseases or inflammatory diseases, containing an effective amount of at least one component selected from the group consisting of a strain according to claim 1 or 2, a culture of said strain, a lysate of said strain, and an extract of said strain.

13. A method for treating intestinal diseases, comprising administering a therapeutically effective amount of at least one component selected from the group consisting of the strain according to claim 1 or 2, cultures of said strain, lysates of said strain and extracts of said strain, to a subject in need thereof.

14. A method for treating allergic diseases, comprising administering a therapeutically effective amount of at least one component selected from the group consisting of the strain according to claim 1 or 2, cultures of said strain, lysates of said strain and extracts of said strain, to a subject in need thereof.

15. A method for treating autoimmune diseases or inflammatory diseases, comprising administering a therapeutically effective amount of at least one component selected from the group consisting of the strain according to claim 1 or 2, cultures of said strain, lysates of said strain and extracts of said strain, to a subject in need thereof.

16. A composition for use in the prevention or treatment of intestinal diseases, containing at least one component selected from the group consisting of the strain according to claim 1 or 2, cultures of said strain, lysates of said strain, and extracts of said strain.

17. A composition for use in the prevention or treatment of allergic diseases, containing at least one component selected from the group consisting of a strain according to claim 1 or 2, cultures of said strain, lysates of said strain, and extracts of said strain.

18. A composition for use in the prevention or treatment of autoimmune diseases or inflammatory diseases, comprising at least one component selected from the group consisting of the strain according to claim 1 or 2, cultures of said strain, lysates of said strain and extracts of said strain.

19. Use of a composition containing at least one component selected from the group consisting of a strain according to claim 1 or 2, cultures of said strain, lysates of said strain and extracts of said strain, for the production of a medicinal product for the prevention or therapy of intestinal diseases.

20. Use of a composition containing at least one component selected from the group consisting of a strain according to claim 1 or 2, cultures of said strain, lysates of said strain and extracts of said strain, for the production of a medicinal product for the prevention or therapy of allergic diseases.

21. Use of a composition containing at least one component selected from the group consisting of a strain according to claim 1 or 2, cultures of said strain, lysates of said strain and extracts of said strain, for the production of a medicinal product for the prevention or therapy of autoimmune diseases or inflammatory diseases.